On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

José Baselga

ResearcherPublications, citations & collaboration network

José Baselga is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does José Baselga have?

ScholarIQindexed works

José Baselga has 368 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does José Baselga have?

ScholarIQcitation count

José Baselga has 76,858 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of José Baselga?

ScholarIQh-index

José Baselga has an h-index of 110 in OpenAlex.

What is the i10-index of José Baselga?

ScholarIQi10-index

José Baselga has an i10-index of 245 in OpenAlex.

What is the OpenAlex record for José Baselga?

ScholarIQopenalex

The OpenAlex for José Baselga is on the source record.

What are the most-cited papers on José Baselga?

ScholarIQmost cited works
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
Dennis J. Slamon, Brian Leyland‐Jones, Steven Shak, H. Fuchs, Virginia Paton, Alex Bajamonde, Thomas Fleming, W. Eiermann, Janet Wolter, Mark D. Pegram, José Baselga, Larry Norton
New England Journal of Medicine. 200111,555 CitationsOPEN ACCESS
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim, Craig H. Mermel, Dale Porter, Guo Wei, Soumya Raychaudhuri, Jerry Donovan, Jordi Barretina, Jesse S. Boehm, Jennifer Dobson, Mitsuyoshi Urashima, Kevin T. Mc Henry, Reid M. Pinchback, Azra H. Ligon, Yoon‐Jae Cho, Leila Haery, Heidi Greulich, Michael Reich, Wendy Winckler, Michael S. Lawrence, Barbara A. Weir, Kumiko Tanaka, Derek Y. Chiang, Adam J. Bass, Alice Loo, Carter Hoffman, John R. Prensner, Ted Liefeld, Qing Gao, Derek Yecies, Sabina Signoretti, Elizabeth A. Maher, Frederic J. Kaye, Hidefumi Sasaki, Joel E. Tepper, Jonathan A. Fletcher, Josep Tabernero, José Baselga, Ming‐Sound Tsao, Francesca Demichelis, Mark A. Rubin, Pasi A. Jänne, Mark J. Daly, Carmelo Nucera, Ross L. Levine, Benjamin L. Ebert, Stacey Gabriel, Anil K. Rustgi, Cristina R. Antonescu, Marc Ladanyi, Anthony Letai, Levi A. Garraway, Massimo Loda, David G. Beer, Lawrence D. True, Aikou Okamoto, Scott L. Pomeroy, Samuel Singer, Todd R. Golub, Eric S. Lander, Gad Getz, William R. Sellers, Matthew Meyerson
Nature. 20104,175 CitationsOPEN ACCESS
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
Alan S. Coates, Eric P. Winer, Aron Goldhirsch, A. Goldhirsch, R.D. Gelber, M. Gnant, M. Piccart-Gebhart, B. Thürlimann, H.-J. Senn, Fabrice André, José Baselga, Jonas Bergh, Hervé Bonnefoi, Harold Burstein, Fatima Cardoso, Monica Castiglione‐Gertsch, Coates As, Marco Colleoni, Giuseppe Curigliano, Nancy E. Davidson, Angelo Di Leo, Bent Ejlertsen, John Forbes, Galimberti, Richard D. Gelber, Michael Gnant, Aron Goldhirsch, Aron Goldhirsch, Pamela Goodwin, N Harbeck, D. F. Hayes, Jens Huober, Clifford A. Hudis, James N. Ingle, J Jassem, Zefei Jiang, P Karlsson, Monica Morrow, R ORECCHIA, C. Kent Osborne, Ann H. Partridge, Lorena de la Peña, Martine J. Piccart-Gebhart, Kathleen I. Pritchard, E Rutgers, Felix Sedlmayer, Vladimir Semiglazov, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Toi M, Gϋnter von Minckwitz, Giuseppe Viale, von Minckwitz G, Toru Watanabe, Timothy Whelan, Eric P. Winer, Binghe Xu
Annals of Oncology. 20151,847 CitationsOPEN ACCESS
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
Luca Gianni, W. Eiermann, Semiglazov Vf, Alexey Manikhas, Aňa Lluch, S. Tjulandin, Milvia Zambetti, Federico Vázquez, Mikhail Byakhow, Mikhail Lichinitser, Miguel Ángel Climent, Eva Ciruelos, B. Ojeda, Mauro Mansutti, А. А. Божок, Roberta Baronio, A. Feyereislova, Claire Barton, Pinuccia Valagussa, José Baselga
The Lancet. 20101,270 Citations
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
John W. Park, Keelung Hong, Dmitri B. Kirpotin, Gail Colbern, Refaat Shalaby, José Baselga, Yvonne Shao, Ulrik B. Nielsen, James D. Marks, Dan H. Moore, Demetrios Papahadjopoulos, Christopher C. Benz
PubMed. 2002648 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account